News | Radiation Therapy | October 30, 2018

Elekta Introduces Strategy for Precision Radiation Medicine at ASTRO 2018

Company highlights Elekta Unity magnetic resonance radiation therapy system and Mosaiq Plaza oncology software

Elekta Introduces Strategy for Precision Radiation Medicine at ASTRO 2018

Elekta SmartClinic is one of the key features in the Mosaiq Plaza suite of data-focused integrative oncology software

October 30, 2018 — At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Elekta introduced the Mosaiq Plaza suite of data-focused integrative oncology software, highlighting the company's comprehensive strategy for precision radiation medicine. This strategy enables complex radiation therapy treatment regimens while simplifying and streamlining the delivery of care. As part of this strategy, the company also highlighted Elekta Unity, its magnetic resonance radiation therapy (MR/RT) system.

Mosaiq Plaza offers delivery of complex precision radiation medicine treatment regimens. The software is a patient-centric, integrative operating system, designed to work seamlessly with Elekta's radiotherapy systems to deliver comprehensive, cost-effective treatment. Elekta said this technology will drive efficient daily practice and connectivity to bring people and information together. Key features include:

  • Elekta SmartClinic: Enables process visualization and automated streamlined care coordination with fewer clicks and portability;
  • Monaco HD treatment planning: With Smart Sequencing and true Multicriterial Optimization, Elekta said Monaco HD achieves superior plan quality with short delivery time;  
  • IBM Watson for Oncology: A tool that augments clinicians' expertise with evidence-based decision support and provides patients with data-driven care regardless of where they are treated;
  • Voice Automation: Integrates Palabra's voice recognition technology and customizable templates with Mosaiq, reducing the time needed to create accurate patients notes; and
  • Care Collaboration: Supports tumor boards and multidisciplinary meeting experiences with cross-specialty data visualization.

Elekta's suite of radiation delivery systems includes:

  • Elekta Unity, the first high-field magnetic resonance radiation therapy (MR/RT) system, which allows clinicians to see and track difficult-to-visualize soft tissue anatomies during radiation dosing;
  • Leksell Gamma Knife Icon for intracranial radiosurgery, which offers HD motion management and stereotactic cone beam computed tomography (CBCT) imaging, allowing for precision radiosurgery with online dose adaptation;
  • Versa HD, a high-definition dynamic radiosurgery (HDRS) platform that offers precision and speed to deliver stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments throughout the body in standard treatment time slots; and
  • Elekta brachytherapy solutions, including Venezia, a gynecologic brachytherapy applicator designed to treat advanced cervical cancer.

For more information: www.elekta.com

Related Content

Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
July 29, 2020 — It has been estimated that the overwhelming focus on...
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...